Expert reaction Professor Ania Jastreboff, who directs the Yale Obesity Research Center, said the trial showed not just significant weight reduction but also improvements in markers of heart and metabolic health, such as blood pressure, cholesterol, and blood sugar control
FCS: Overall the safety of these drugs is very similar
These unfolded molecules stick together, forming clumps that reduce the effective dose and can potentially cause injection site reactions
Our calculator uses a data-driven model to project your personalized weight loss journey
The European Supplementary Protection Certificate (SPC) In Europe, the Supplementary Protection Certificate (SPC) provides an extension of up to five years for patents on medicinal products that require marketing authorization
GLP-1RA intervention was not associated with increased dizziness events when compared to those given metformin or placebo (OR = 1.20